Purpose: The utility of the apparent diffusion coefficient (ADC) in patients with clear-cell renal cell carcinoma (RCC) for distinguishing between the four clinical stages was assessed.
Methods: Forty-nine patients with pathologically proven RCCs (I, II, III, IV; 27, 5, 10, 7) were included. The ADC was compared between each stage.
Results: The difference of ADC between stage I and the more advanced stages (III and IV) was statistically significant.
Conclusions: When ADC in primary tumor site of clear-cell RCC would be higher than the cutoff level, the stage might not be an advanced stage (III or IV).
Keywords: Apparent diffusion coefficients (ADC); Clinical stage; Magnetic resonance (MR) imaging; Renal cell carcinoma.
Copyright © 2015 Elsevier Inc. All rights reserved.